Role of daratumumab in the frontline management of multiple myeloma: a narrative review.

导出 LinkOut

翻译打印收藏纠错

作者： Sanjeev,Yadav ^[1] ; Sadashivudu,Gundeti ^[2] ; Abhay,Bhave ^[3] ; Uttiya,Deb ^[4] ; Jitendra,Dixit ^[4] ; Kundan,Mishra ^[5]

作者单位： Department of Hematology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India. ^[1] Department of Medical Oncology, Nizam's Institute of Medical Sciences, Hyderabad, India. ^[2] Department of Hematology, Lilavati Hospital and Research Centre, Mumbai, India. ^[3] Medical Affairs, Johnson and Johnson Private Limited, Mumbai, India. ^[4] Department of Hematology, Command Hospital, Lucknow, India. ^[5]

关键词 Daratumumab high-risk minimal residual disease multiple myeloma newly diagnosed multiple myeloma relapsed/refractory multiple myeloma

主题词人类(Humans);多发性骨髓瘤(Multiple Myeloma);肿瘤复发, 局部(Neoplasm Recurrence, Local);抗体, 单克隆(Antibodies, Monoclonal);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);地塞米松(Dexamethasone)

DOI 10.1080/17474086.2023.2246651

PMID 37585685

发布时间 2024-01-24

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Expert review of hematology

743-760页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Role of daratumumab in the frontline management of multiple myeloma: a narrative review.

Expert review of hematology

相似文献

Expert review of hematology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Role of daratumumab in the frontline management of multiple myeloma: a narrative review.

Expert review of hematology

相似文献

Expert review of hematology

相关期刊

检索历史清除